SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-282510
Filing Date
2019-11-04
Accepted
2019-11-04 07:23:30
Documents
71
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d810264d10q.htm   iXBRL 10-Q 3599949
2 EX-10.2 d810264dex102.htm EX-10.2 519276
3 EX-31.1 d810264dex311.htm EX-31.1 6486
4 EX-31.2 d810264dex312.htm EX-31.2 6576
5 EX-32.1 d810264dex321.htm EX-32.1 3957
6 EX-32.2 d810264dex322.htm EX-32.2 3944
  Complete submission text file 0001193125-19-282510.txt   11798519

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA kpti-20190930.xsd EX-101.SCH 46675
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kpti-20190930_cal.xml EX-101.CAL 46448
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kpti-20190930_def.xml EX-101.DEF 267840
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE kpti-20190930_lab.xml EX-101.LAB 414829
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kpti-20190930_pre.xml EX-101.PRE 368941
68 EXTRACTED XBRL INSTANCE DOCUMENT d810264d10q_htm.xml XML 2372559
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36167 | Film No.: 191188250
SIC: 2834 Pharmaceutical Preparations